Similar Pharmacokinetics and Pharmacodynamics of Biosimilar SAR342434 Insulin Lispro and Japan‐Approved Humalog Insulin Lispro in Healthy Japanese Subjects

This phase 1 study compared the pharmacokinetic (PK) and glucose pharmacodynamic (PD) characteristics of biosimilar SAR342434 insulin lispro and Japan‐reference Humalog insulin lispro. This was a randomized, double‐blind, 2‐period, crossover study. Thirty‐six healthy Japanese male subjects underwent...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiramoto, Masanari, Yoshihara, Tatsuya, Schmider, Wolfgang, Takahashi, Yoshinori, Nowotny, Irene, Kajiwara, Miyuki, Muto, Hideya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305226/
https://www.ncbi.nlm.nih.gov/pubmed/35166054
http://dx.doi.org/10.1002/cpdd.1068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305226/
https://www.ncbi.nlm.nih.gov/pubmed/35166054
http://dx.doi.org/10.1002/cpdd.1068

Ejemplares similares